title: Adjuvant tamoxifen in breast-cancer-treatment in postmenopausal women - occurrence of thromboembolic complications.
abstract: Of 441 postmenopausal breast cancer patients who received adjuvant tamoxifen, 19 had thromboembolic accidents (4.3%). All were in remission when thrombosis occurred. One patient died of bilateral pulmonary embolism. In the other cases, thromboembolic disorders were found to be reversible after the withdrawal of tamoxifen and anticoagulant treatment. Some patients had a history of vascular disorders, and others required prolonged bed rest which may have contributed as an aggravating circumstance to thrombotic events. Our study suggests that thromboembolic risk factors as well as potential vascular disorders induced by aggravating conditions have to be carefully examined in postmenopausal patients treated by adjuvant tamoxifen therapy. This is especially true in women with lobular breast cancer and aged more than 60 years.
authors: CTR PAUL STRAUSS,DEPT MED,F-67085 STRASBOURG,FRANCE. CTR PAUL STRAUSS,DEPT BIOSTAT,F-67085 STRASBOURG,FRANCE.
authors: B
authors: B
authors: Cutuli
authors: J
authors: J
authors: Petit
authors: J
authors: J
authors: Fricker
authors: G
authors: G
authors: Jung
authors: C
authors: C
authors: Schumacher
authors: M
authors: M
authors: Velten
authors: J
authors: J
authors: Abecassis